Jun 29, 2026
Joseph Pandolfino, Founder and CEO of Cabbacis, is focused on reducing harm caused by smoking cigarettes by developing cigarettes made from a blend of low-nicotine tobacco and hemp. This approach is intended to help smokers reduce their nicotine dependence and increase the success rate of those who are looking to quit smoking. Their products are targeted to established smokers by providing the taste and sensory experience of a traditional cigarette while providing significantly less nicotine and a path to less harmful non-combustible products.
Joseph explains, "So our products in development are called iBlend. We'll stick with the cigarette right now. So iBlend is predominantly very low-nicotine tobacco, and you add hemp to the product. Hemp became legal at the federal level in 2018 for farmers. So every iBlend is the merger of very low-nicotine tobacco and hemp, which really creates the taste and sensory characteristics of a cigarette that just has very little nicotine tobacco."
"As I mentioned, currently nicotine is reduced by about 95%. They give you a little bit of nicotine but not enough to really sustain addiction. So the result is that people smoke less cigarettes and it has greatly increased their quit attempts. And while they reduce their nicotine exposure and dependence, if they choose to switch to a non-combustible, we consider that a win as far as we're concerned."
#Cabbacis $CABI #EmpoweredPatient #HarmReduction #TobaccoHarmReduction #SmokingCessation #QuitSmoking #iBlend #FDA #PublicHealth #TobaccoControl #PublicHealth #Healthcare
